Clinical Trial Update: Oculusgen (Ologen) Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: A Case-Control Study [Phase 3]

View source ↗

Summary

A Phase 3 case-control clinical trial evaluates the Oculusgen (Ologen) Collagen Matrix Implant as an adjunct to phaco-trabeculectomy for primary glaucoma, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Glaucoma

Drugs mentioned

• Oculusgen (Ologen) Collagen Matrix Implant (Ologen Collagen Matrix Implant)

Snippet

Sponsor: Pro Top & Mediking Company Limited | Conditions: Cataract, Glaucoma | Phase 3 | Status: UNKNOWN